BESREMi 500 ug/mL
ROPEGINTERFERON ALFA-2B · INJECTION · PharmaEssentia USA
No Recall History
Plain English
BESREMi is a injection containing ropeginterferon alfa-2b at 500 ug/mL, taken subcutaneous. Manufactured by PharmaEssentia USA.
Key Facts
- Brand Name
- BESREMi
- Generic Name
- ROPEGINTERFERON ALFA-2B
- NDC Code (Product)
73536-500- Manufacturer
- PharmaEssentia USA
- Strength
- 500 ug/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761166
- Drug Class
- Interferon alfa-2b [EPC]
- Marketing Start
- 11/12/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is BESREMi used for?
BESREMi contains ROPEGINTERFERON ALFA-2B. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is BESREMi a controlled substance?
BESREMi is not classified as a controlled substance by the DEA.
What is the generic name for BESREMi?
The generic name for BESREMi is ROPEGINTERFERON ALFA-2B. There are no other listed brand versions of ROPEGINTERFERON ALFA-2B.
What is the NDC code for BESREMi 500 ug/mL?
The NDC (National Drug Code) for BESREMi 500 ug/mL is 73536-500, listed by PharmaEssentia USA.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)